-
China’s NHSA Releases 2024 Healthcare Security Bulletin Highlighting Insurance Coverage and Reimbursement
•
China’s National Healthcare Security Administration (NHSA) has released its 2024 “Healthcare Security Development Statistical Bulletin.” The report reveals that by the end of 2024, over 1.33 billion people were enrolled in Basic Medical Insurance (BMI) schemes, maintaining a coverage rate of over 95%. Maternity insurance participation reached 252.98 million, an…
-
China’s NHSA Issues Guidelines for Neurological Medical Services Pricing
•
China’s National Healthcare Security Administration (NHSA) has released the “Guidelines for the Pricing Project Initiation for Neurological Medical Services (Trial)”, aimed at guiding provincial healthcare security administration bureaus to formulate unified provincial price benchmarks. This initiative integrates the current pricing items for the nervous system into 82 items, including 24…
-
In-Depth Analysis of the National Healthcare Security Policy: A Guide to Key Reforms and Implications
•
The National Healthcare Security Administration (NHSA) has unveiled its 2025 priority action list, focusing on improving efficiency and accessibility in healthcare services. This policy reform targets three key stakeholders: designated medical institutions, pharmaceutical companies, and insured individuals, introducing six major service initiatives. Below is a detailed analysis of the reforms,…
-
China’s Drug Procurement Under Scrutiny: Addressing Quality Concerns and Policy Reforms
•
An In – Depth Exploration of the Recent Survey on Bulk Drug Procurement in China and the Responses to Public ConcernsIn January of this year, concerns were raised by some experts about the potential quality risks of certain drugs under the centralized bulk procurement system in China, such as “ineffective…
-
In-Depth Analysis of NHSA’s DRG/DIP Payment Reforms: A Path to Streamlined Healthcare Management
•
Comprehensive Overhaul of Payment SystemsThe National Healthcare Security Administration (NHSA) has unveiled a series of measures aimed at enhancing the management of Diagnosis Related Groups (DRG) and Diagnosis-Intervention Packet (DIP) payment methods within China’s multi-tiered healthcare security framework, known as the “1+3+N” system. These reforms emphasize seamless integration with other…
-
NHSA Regulates DRG/DIP Payment Methods Under ‘1+3+N’ System
•
The National Healthcare Security Administration (NHSA) has released a set of regulations aimed at improving the management of Diagnosis Related Groups (DRG) and Diagnosis-Intervention Packet (DIP) payment methods under the multi-level medical security system of “1+3+N”. The document emphasizes the need for better coordination between payment methods and reforms in…
-
China’s NHSA and MoF Push for DRG/DIP Payment Reforms by 2025
•
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly released a notification requiring all provinces to include the direct settlement of hospitalization expenses in other places within the province in the Diagnosis Related Groups (DRG) and Diagnosis-Intervention Packet (DIP) payment systems by the end of…
-
NHSA Targets Low-Volume Drugs in National Reimbursement List
•
The National Healthcare Security Administration (NHSA) in China has released a list of 131 drugs that are included in the National Reimbursement Drug List (NRDL) but have seen little trade volume. The move aims to ensure the basic medication needs of insured patients by monitoring the production and supply of…
-
NHSA Outlines 2025 Work Plan and 2024 Medical Insurance Status
•
The National Healthcare Security Administration (NHSA) last week held a press conference, addressing questions regarding the medical insurance operation status in 2024 and outlining the 2025 work plan. The conference provided detailed insights into the performance of the national basic medical insurance (BMI) fund and future policy directions. 2024 Medical…
-
NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy
•
The National Healthcare Security Administration (NHSA) has released a letter titled “Letter on Requesting Assistance in Hearing Opinions on Volume-based Procurement (VBP) of Drugs Face to Face.” The NHSA will visit Shanghai to listen to the opinions and suggestions of relevant committee members and experts on VBP policy and the…
-
NHSA Pushes for Real-Time Settlement Reform in Basic Medical Insurance
•
The National Healthcare Security Administration (NHSA) has released a notification to promote the real-time settlement reform of the basic medical insurance (BMI) fund. The goal is to achieve real-time settlement in about 80% of the overall planning areas in China by 2025, with all areas expected to implement the reform…
-
Suzhou Ribo and Boehringer Ingelheim Reach Pre-Clinical Milestone in NASH/MASH Partnership
•
China-based Suzhou Ribo Life Science Co., Ltd has announced the achievement of a first pre-clinical milestone by Germany-headquartered Boehringer Ingelheim (BI) as part of their partnership struck back in January of last year. This milestone marks a significant step forward in the joint development of siRNA drugs for the treatment…
-
NHSA Launches Nationwide Self-Inspection Campaign on Medical Insurance Fund Usage
•
China’s National Healthcare Security Administration (NHSA) released a notification last weekend, mandating designated medical institutions to conduct self-inspections and self-corrections regarding the illegal and irregular use of medical insurance funds. This initiative aims to enhance the integrity and efficiency of fund utilization within the healthcare sector. Expansion of Campaign ScopeThis…
-
China’s NHSA Implements New Regulations for Medical Insurance Payment Qualifications
•
China’s National Healthcare Security Administration (NHSA) has released the “Regulations on the Management of Medical Insurance Payment Qualifications for Personnel in Medical Security Designated Medical Institutions.” These regulations aim to enhance the rational use of medical insurance funds and maintain fund security through improved management efforts. The document came into…
-
NHSA Strengthens Medical Security Rights for Workers in China
•
China’s National Healthcare Security Administration (NHSA) has released the “Notice on Further Strengthening the Protection of Workers’ Medical Security Rights and Interests.” The notice suggests that all localities promote megacities to completely eliminate registered residence restrictions on flexible employment personnel to participate in insurance in the place of employment, ensuring…
-
China’s Healthcare Bureaus Remove Drug Quantity Limits to Enhance NRDL Access
•
The healthcare security administration bureaus in Shanghai, Beijing, and other regions have recently removed limits on drug use quantities in hospitals. This move is aimed at bolstering the access of drugs listed on the National Reimbursement Drug List (NRDL) to healthcare facilities. Shanghai’s Initiatives for NRDL Drug ProcurementShanghai’s healthcare security…
-
Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress
•
A national conference on healthcare security was recently held in Beijing, reviewing the achievements of 2024 and setting the agenda for 2025. The conference highlighted new developments in medical reform across various fronts. Advancements in Medical Reform in 2024 Universal Insurance CoverageThe conference reported that universal insurance coverage has entered…
-
China’s NHSA and NHC Issue Guidelines to Enhance Volume-based Procurement Mechanism
•
The National Healthcare Security Administration (NHSA) and National Health Commission (NHC) of China have released the “Notice on Improving the Working Mechanism for Volume-based Procurement (VBP) and its Implementation.” The notice outlines refined measures for hospital access, use, monitoring, examination, and feedback in relation to VBP drugs and consumables. Urging…
-
China’s NHC Launches Pilot Plan to Expand Wholly Foreign-Owned Hospital Sector
•
The National Health Commission (NHC) has released the “Pilot Work Plan for Expanding the Wholly Foreign-Owned Hospital Sector,” supported by the Ministry of Commerce (MOC), National Administration of Traditional Chinese Medicine, and National Bureau of Disease Control and Prevention. This policy aims to set specific requirements for the operation of…
-
National Reimbursement Drug List 2024 Expands Coverage with 91 New Drugs
•
The National Medical Products Administration has released the finalized National Reimbursement Drug List (NRDL) for 2024, which includes 91 new drugs. Among these, 89 were added through negotiation/pricing bidding, and 2 were winning bids in the volume-based procurement (VBP). Concurrently, 43 drugs that had been supplanted in clinical use or…
